custom image

Integrating Metabolism and Immunity

January 25-28, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.


Apply Here


Traditionally, metabolism and immunity have been perceived as two distinct systems with distinct functions: metabolism regulates the disposal and transformation of nutrients, whereas the immune system is responsible for host defense. However, in a broader sense, these two processes are both an organism’s response to stressors, with the aim of restoring homeostasis. An increasing amount of evidence has demonstrated that the chronic activation of the immune system associated with overnutrition may be deleterious, contributing importantly to diabetes and long-term complications, such as cardiovascular disorders. Such dysregulation of the immune system may reflect the duration and magnitude of the metabolic stress, along with genetic predispositions. Accordingly, anti-inflammatory treatments of metabolic diseases emerge as therapies interfering with the pathogenesis of these illnesses and offer disease-modifying potential. Therefore, it is critical that clinical translation be based on an understanding of the physiology and pathophysiology of the role of the immune system in metabolism. This conference will bring together basic scientists and clinicians from both disciplines in order to spark innovative ways of understanding the interactions between the immune system and metabolism. The conference organizers anticipate that the conference will lead to the development of novel therapeutic concepts based on the pathways underlying the pathogenesis of diseases rather than on the manifestation of symptoms belonging to a specific clinical discipline.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission:
‣ For Short Talk Consideration: Passed
‣ For Poster Booth: Passed
ePoster / SciTalk Submission: January 14, 2021
Financial Aid Application: Passed

*Please note, abstract submission is required
in order to submit an ePoster and/or Scitalk

#VKSMetaImmune21



Program Details



Speaking at this eSymposia


Janelle S. Ayres

The Salk Institute for Biological Studies, USA


Morris J. Birnbaum

Pfizer Inc., USA


Paul Cohen

Rockefeller University, USA


Elise Dalmas

INSERM, France


Vishwa Deep Dixit

Yale University, USA


Ana Domingos

University of Oxford, UK



Marc Y. Donath

University Hospital Basel, Switzerland


Helga Ellingsgaard

Centre for Physical Activity Research, Copenhagen, Denmark


Mark A. Febbraio

Monash Institute of Pharmaceutical Sciences, Australia


Ruth A. Franklin

Harvard University, USA


Christoph Hess

University Hospital Basel, Switzerland


Michael Karin

University of California, San Diego, USA


Eicke Latz

University of Bonn, Germany


Diane Mathis

Harvard Medical School, USA


Marina Mesquida

F. Hoffmann-La Roche Ltd, Switzerland


Evanna Mills

Dana-Farber Cancer Institute, USA


Matthias Nahrendorf

Massachusetts General Hospital, USA


Luke A. J. O'Neill

Trinity Biomedical Sciences Institute, Ireland


Gwendalyn J. Randolph

Washington University, USA


Alan R. Saltiel

University of California, San Diego, USA


Bruce M. Spiegelman

Harvard Medical School, USA


Rinke Stienstra

Wageningen University, Netherlands


Tom Thuren

Novartis Pharmaceuticals, USA


Bruce Verchere

University of British Columbia, Canada


Amy J. Wagers

Harvard University, USA


Jun Wu

University of Michigan, USA





Sponsors


sponsor-carousel-abbvie.png

sponsor-carousel-astellas-pharma.png

sponsor-carousel-cell-research.png

sponsor-carousel-merck.png

 

Sponsor-carousel-novo-norodisk.png

 




Additional Support



sponsor-carousel-Adipogen-life-sciences.png

sponsor-carousel-bmgf.png

sponsor-carousel-nih-NIDDKD.png

sponsor-carousel-sable-systems.png

Funding for this conference was made possible (in part) by Grant No. 1 R13 DK125009-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

sponsor-carousel-scientist.png



#ScienceMustGoOn


This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.







The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






Related Keystone Symposia In-Person Meetings

Explore all cancer-related meetings on the Keystone Symposia website.

custom image

custom image

custom image






Donate to Keystone Symposia


custom image